clofibrate has been researched along with Liver Diseases in 16 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypothyroidism is common in the elderly, especially among women." | 1.33 | [Hypolipidemic therapy in special situations: hypothyroidism and liver disease]. ( Cesena, FH; Luz, PL; Xavier, HT, 2005) |
| "Clofibrate treatment elevated the levels of N-methylnicotinamide and 3,4-dihydroxymandelate and decreased the levels of 2-oxoglutarate and N-acetylaspartate." | 1.33 | A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats. ( Aoki, T; Ishihara, K; Katsutani, N, 2006) |
| "Treatment with clofibrate is known to increase drastically the number of peroxisomes in mammalian liver." | 1.27 | Unsuccessful attempts to induce peroxisomes in two cases of Zellweger disease by treatment with clofibrate. ( Björkhem, I; Blomstrand, S; Glaumann, H; Strandvik, B, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Zhang, P | 1 |
| Ge, X | 1 |
| Wu, Q | 1 |
| Han, C | 1 |
| Zhang, L | 1 |
| Hua, Y | 1 |
| Zhang, Y | 1 |
| Liu, J | 1 |
| Shi, Y | 1 |
| Wang, B | 1 |
| Wang, X | 1 |
| Wang, W | 1 |
| Jiang, Y | 1 |
| Zhang, H | 1 |
| Deng, C | 1 |
| Xie, Y | 1 |
| Liu, Y | 1 |
| He, S | 1 |
| BEST, MM | 1 |
| DUNCAN, CH | 1 |
| Bertolami, MC | 1 |
| Cesena, FH | 1 |
| Xavier, HT | 1 |
| Luz, PL | 1 |
| Ishihara, K | 1 |
| Katsutani, N | 1 |
| Aoki, T | 1 |
| Moffit, JS | 1 |
| Koza-Taylor, PH | 1 |
| Holland, RD | 1 |
| Thibodeau, MS | 1 |
| Beger, RD | 1 |
| Lawton, MP | 1 |
| Manautou, JE | 1 |
| Carfagna, MA | 1 |
| Young, KM | 1 |
| Susick, RL | 1 |
| Dry, J | 1 |
| Pradalier, A | 1 |
| Gugler, R | 1 |
| Kürten, JW | 1 |
| Jensen, CJ | 1 |
| Klehr, U | 1 |
| Hartlapp, J | 1 |
| Schade, RW | 1 |
| Demacker, PN | 1 |
| van't Laar, A | 1 |
| Cayen, MN | 1 |
| Björkhem, I | 1 |
| Blomstrand, S | 1 |
| Glaumann, H | 1 |
| Strandvik, B | 1 |
| Sachs, BA | 1 |
| Bardfeld, PA | 1 |
| Bodian, JE | 1 |
| Sugarman, LA | 1 |
| Hellman, L | 1 |
| O'Reilly, RA | 2 |
| Aggeler, PM | 1 |
| Moschella, SL | 1 |
4 reviews available for clofibrate and Liver Diseases
| Article | Year |
|---|---|
[Therapeutics in 1978].
Topics: Amenorrhea; Anticholesteremic Agents; Artificial Organs; Biliary Tract Diseases; Bromocriptine; Chol | 1978 |
Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.
Topics: Animals; Binding Sites; Biological Availability; Biotransformation; Clofibrate; Drug Interactions; H | 1985 |
Drug interactions involving oral anticoagulants.
Topics: Animals; Anticoagulants; Barbiturates; Blood Coagulation; Blood Coagulation Factors; Cholestyramine | 1974 |
Determinants of the response to oral anticoagulant drugs in man.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anticoagulants; Blood | 1970 |
1 trial available for clofibrate and Liver Diseases
| Article | Year |
|---|---|
Liver scan in hyperlipoproteinemia.
Topics: Adult; Aged; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Ch | 1974 |
11 other studies available for clofibrate and Liver Diseases
| Article | Year |
|---|---|
Optimization of clofibrate with O-desmethyl anetholtrithione lead to a novel hypolipidemia compound with hepatoprotective effect.
Topics: Anethole Trithione; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Li | 2022 |
HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
Topics: Adrenalectomy; Androsterone; Anticholesteremic Agents; Butyrates; Castration; Cholesterol; Clofibrat | 1964 |
[Mechanisms of hepatotoxicity].
Topics: Chemical and Drug Induced Liver Injury; Clofibrate; Drug Interactions; Humans; Hydroxymethylglutaryl | 2005 |
[Hypolipidemic therapy in special situations: hypothyroidism and liver disease].
Topics: Age Factors; Azetidines; Clofibrate; Drug Interactions; Dyslipidemias; Ezetimibe; Female; Humans; Hy | 2005 |
A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats.
Topics: Aniline Compounds; Animals; Chemical and Drug Induced Liver Injury; Clofibrate; Galactosamine; Liver | 2006 |
Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
Topics: Acetaminophen; Acyl-CoA Oxidase; Amidohydrolases; Animals; Anticholesteremic Agents; Cell Adhesion M | 2007 |
Sex differences in rat hepatic cytolethality of the protein kinase C inhibitor safingol: role of biotransformation.
Topics: Administration, Oral; Animals; Biotransformation; Cell Count; Cell Death; Cell Survival; Cells, Cult | 1996 |
Clofibrate disposition in renal failure and acute and chronic liver disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Clofibrate; Female; Half-Life; Humans; Kidn | 1979 |
Clofibrate effect on alkaline phosphatase: bone or liver fraction.
Topics: Alkaline Phosphatase; Bone and Bones; Clofibrate; Humans; Liver; Liver Diseases; Osteitis Deformans | 1977 |
Unsuccessful attempts to induce peroxisomes in two cases of Zellweger disease by treatment with clofibrate.
Topics: Abnormalities, Multiple; Brain Diseases; Clofibrate; Female; Humans; Infant; Kidney Diseases; Liver | 1985 |
Xanthomatosis, associated with multiple myeloma.
Topics: Clofibrate; Humans; Lipid Metabolism; Liver Diseases; Male; Melphalan; Middle Aged; Multiple Myeloma | 1970 |